Journal of the Korean Ophthalmological Society 2000;41(5):1089-1094.
Published online May 1, 2000.
Toxi city Study of Intrav it real Interfe ron-alpha in Rabbits.
Hyoung Jun Koh, Jae In Jung, Soon Hyun Kim, Oh Woong Kwon
1Department of Ophthalmology, Yonsei University College Medicine, Seoul, Korea.
2The Institute of Vision Research, Yonsei University College Medicine, Seoul, Korea.
가토에서 Interferon - α 의 유리체 강내 주입시 농도에 따른 독성 비교
고형준(Hyoung Jun Koh),정재인(Jae In Jung),김순현(Soon Hyun Kim),권오웅(Oh Woong Kwon)
Abstract
Interferon-alpha is known to inhibit the vascular endothelial cell proliferation and migration in vitro.It has been used systemically for the treatment of choroidal neovascular membrane proliferation.However, significant side effects in systemic administration limit the dosage and duration of its use. It has been suggested that reducing systemic side effects and maintenance of high intraocular concentration would be achieved with the direct intravitreal injection of Interferon-alpha.Thus, this study was undertaken to estimate the toxicity and safe dose of Interferon-alpha when it is given intravitreally in rabbits. Normal saline, Interferon-alpha 50, 000IU, 100, 000IU, 200, 000IU and 300, 000 IU were given intravitreally to 10 rabbit eyes.Toxicity was assessed by serial ERGs after 7 and 14 days.Animals were sacrificed at 14 days after injection for histopathologic study. The ERG was flattened at 14 days in 300, 000IU of Interferon-alpha group.On histologic examination, inflammatory reaction of vitreous and retina remained at an insignificant level upto 200, 000IU, but increased in dose dependent manner above this dose, resulting in prominent reaction in 300, 000IU group. Therefore, we suggest that 200, 000IU of Interferon-alpha may be the safe dose when administered intravitreally in rabbits, and 300, 000IU may be the toxic dose.
Key Words: Choroidal neovascular membrane;Interferon-a;Intravitreal;Toxicity


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next